311 related articles for article (PubMed ID: 21621834)
1. Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia.
Belch J; Hiatt WR; Baumgartner I; Driver IV; Nikol S; Norgren L; Van Belle E;
Lancet; 2011 Jun; 377(9781):1929-37. PubMed ID: 21621834
[TBL] [Abstract][Full Text] [Related]
2. Insights on the role of diabetes and geographic variation in patients with critical limb ischaemia.
Van Belle E; Nikol S; Norgren L; Baumgartner I; Driver V; Hiatt WR; Belch J
Eur J Vasc Endovasc Surg; 2011 Sep; 42(3):365-73. PubMed ID: 21696982
[TBL] [Abstract][Full Text] [Related]
3. Gene therapy for critical limb ischaemia: the TAMARIS trial.
Fowkes FG; Price JF
Lancet; 2011 Jun; 377(9781):1894-6. PubMed ID: 21621833
[No Abstract] [Full Text] [Related]
4. Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia.
Nikol S; Baumgartner I; Van Belle E; Diehm C; Visoná A; Capogrossi MC; Ferreira-Maldent N; Gallino A; Wyatt MG; Wijesinghe LD; Fusari M; Stephan D; Emmerich J; Pompilio G; Vermassen F; Pham E; Grek V; Coleman M; Meyer F;
Mol Ther; 2008 May; 16(5):972-8. PubMed ID: 18388929
[TBL] [Abstract][Full Text] [Related]
5. Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial.
Comerota AJ; Throm RC; Miller KA; Henry T; Chronos N; Laird J; Sequeira R; Kent CK; Bacchetta M; Goldman C; Salenius JP; Schmieder FA; Pilsudski R
J Vasc Surg; 2002 May; 35(5):930-6. PubMed ID: 12021709
[TBL] [Abstract][Full Text] [Related]
6. Local gene transfer and expression following intramuscular administration of FGF-1 plasmid DNA in patients with critical limb ischemia.
Baumgartner I; Chronos N; Comerota A; Henry T; Pasquet JP; Finiels F; Caron A; Dedieu JF; Pilsudski R; Delaère P
Mol Ther; 2009 May; 17(5):914-21. PubMed ID: 19240689
[TBL] [Abstract][Full Text] [Related]
7. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial.
Adam DJ; Beard JD; Cleveland T; Bell J; Bradbury AW; Forbes JF; Fowkes FG; Gillepsie I; Ruckley CV; Raab G; Storkey H;
Lancet; 2005 Dec; 366(9501):1925-34. PubMed ID: 16325694
[TBL] [Abstract][Full Text] [Related]
8. PLX-PAD Cell Treatment of Critical Limb Ischaemia: Rationale and Design of the PACE Trial.
Norgren L; Weiss N; Nikol S; Hinchliffe RJ; Lantis JC; Patel MR; Reinecke H; Ofir R; Rosen Y; Peres D; Aberman Z
Eur J Vasc Endovasc Surg; 2019 Apr; 57(4):538-545. PubMed ID: 30686676
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety of intramuscular gene transfer of non-viral FGF1 for peripheral artery disease.
Niebuhr A; Henry T; Goldman J; Baumgartner I; van Belle E; Gerss J; Hirsch AT; Nikol S
Gene Ther; 2012 Mar; 19(3):264-70. PubMed ID: 21716303
[TBL] [Abstract][Full Text] [Related]
10. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia.
Powell RJ; Simons M; Mendelsohn FO; Daniel G; Henry TD; Koga M; Morishita R; Annex BH
Circulation; 2008 Jul; 118(1):58-65. PubMed ID: 18559703
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia.
Nikol S; Baumgartner I; Van Belle E; Diehm C; Visoná A; Capogrossi MC; Ferreira-Maldent N; Gallino A; Graham Wyatt M; Dinesh Wijesinghe L; Fusari M; Stephan D; Emmerich J; Pompilio G; Vermassen F; Pham E; Grek V; Coleman M; Meyer F
Mol Ther; 2008 May; 16(5):972-978. PubMed ID: 28178491
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic angiogenesis using gene transfer and stem cell therapy in peripheral artery disease].
Nikol S
Dtsch Med Wochenschr; 2011 Apr; 136(14):672-4. PubMed ID: 21448824
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Immediate and Long-term Outcomes in Men and Women Undergoing Revascularisation for Chronic Limb Threatening Ischaemia in the Bypass vs. Angioplasty in Severe Ischaemia of the Leg (BASIL-1) Trial.
Benson RA; Meecham LA; Hewitt CA; Bradbury AW
Eur J Vasc Endovasc Surg; 2019 Aug; 58(2):224-228. PubMed ID: 31201136
[TBL] [Abstract][Full Text] [Related]
14. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
Weisz G; Généreux P; Iñiguez A; Zurakowski A; Shechter M; Alexander KP; Dressler O; Osmukhina A; James S; Ohman EM; Ben-Yehuda O; Farzaneh-Far R; Stone GW;
Lancet; 2016 Jan; 387(10014):136-45. PubMed ID: 26474810
[TBL] [Abstract][Full Text] [Related]
15. Skin perfusion pressure measurement is valuable in the diagnosis of critical limb ischemia.
Castronuovo JJ; Adera HM; Smiell JM; Price RM
J Vasc Surg; 1997 Oct; 26(4):629-37. PubMed ID: 9357464
[TBL] [Abstract][Full Text] [Related]
16. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial.
Anand SS; Bosch J; Eikelboom JW; Connolly SJ; Diaz R; Widimsky P; Aboyans V; Alings M; Kakkar AK; Keltai K; Maggioni AP; Lewis BS; Störk S; Zhu J; Lopez-Jaramillo P; O'Donnell M; Commerford PJ; Vinereanu D; Pogosova N; Ryden L; Fox KAA; Bhatt DL; Misselwitz F; Varigos JD; Vanassche T; Avezum AA; Chen E; Branch K; Leong DP; Bangdiwala SI; Hart RG; Yusuf S;
Lancet; 2018 Jan; 391(10117):219-229. PubMed ID: 29132880
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of direct and indirect endovascular revascularization based on the angiosome concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions.
Iida O; Soga Y; Hirano K; Kawasaki D; Suzuki K; Miyashita Y; Terashi H; Uematsu M
J Vasc Surg; 2012 Feb; 55(2):363-370.e5. PubMed ID: 22051875
[TBL] [Abstract][Full Text] [Related]
18. Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients.
Abdul Wahid SF; Ismail NA; Wan Jamaludin WF; Muhamad NA; Abdul Hamid MKA; Harunarashid H; Lai NM
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010747. PubMed ID: 30155883
[TBL] [Abstract][Full Text] [Related]
19. Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.
Kusumanto YH; van Weel V; Mulder NH; Smit AJ; van den Dungen JJ; Hooymans JM; Sluiter WJ; Tio RA; Quax PH; Gans RO; Dullaart RP; Hospers GA
Hum Gene Ther; 2006 Jun; 17(6):683-91. PubMed ID: 16776576
[TBL] [Abstract][Full Text] [Related]
20. Surgical management of critical limb ischaemia in the French West Indies.
Deneuville M
West Indian Med J; 1998 Sep; 47(3):94-7. PubMed ID: 9861859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
